21-day Double-blind Trial of Albendazole in Adults With Loa Loa Microfilaremia

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Loiasis With Positive Blood MicrofilaremiaLoiasis

Interventions

DRUG

Albendazole 400mg

Albendazole 400mg per days for 21 consecutive days

DRUG

Placebo

Placebo for 21 consecutive days

All Listed Sponsors

collaborator

Institut de Recherche pour le Developpement

OTHER_GOV

lead

Programme National de Lutte contre l'Onchocercose, Republic of the Congo

OTHER_GOV